Skip to main content
Evolva Holding SA logo

Evolva Holding SA — Investor Relations & Filings

Ticker · EVE ISIN · CH1262055788 LEI · 506700IF701J35J34N57 SW Financial and insurance activities
Open in API
Filings indexed 77 across all filing types
Latest filing 2024-07-15 Delisting Announcement
Country CH Switzerland
Listing SW EVE

About Evolva Holding SA

https://evolva.com/

EvoNext Holdings SA, formerly Evolva Holding SA, is a biotechnology company that researches, develops, and commercializes nature-based ingredients. The company focuses on providing innovative and sustainable solutions for various industries, with primary applications in flavors and fragrances, health ingredients, and nutrition. Its mission is to leverage biotechnology to discover and produce high-quality ingredients for health and wellness markets.

Recent filings

Filing Released Lang Actions
Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 LR; IFRS financial statements for 2023 and half-year 2024 to be published by 31 October 2024
Delisting Announcement Classification · 99% confidence The document is explicitly labeled as an 'Ad-hoc Announcement pursuant to Art. 53 LR' and is a press release detailing a regulatory decision from SIX Exchange Regulation AG (SER) regarding an extension for publishing financial statements (IFRS 2023 and H1 2024) until October 31, 2024. It is not the financial report itself (like 10-K or IR), nor is it a transcript (CT) or a standard earnings release (ER). Since it is a specific regulatory announcement concerning listing rules and publication deadlines, and it doesn't fit perfectly into the other specific categories (like DIRS, DIV, MANG), the most appropriate general category for miscellaneous regulatory news that doesn't fit elsewhere is 'Regulatory Filings' (RNS). However, given the content is a direct announcement about the status of required financial reporting and regulatory compliance, it functions as a general regulatory update. Since the document is announcing the *postponement* of the publication of the Annual Report (10-K) and Interim Report (IR), and it is a short, timely announcement, it fits best under the general regulatory announcement category.
2024-07-15 English
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
AGM Information Classification · 99% confidence The document explicitly states that the company 'today held its Annual General Meeting (“AGM”) in Basel' and details the results of the shareholder votes on various proposals, including the approval of liquidation interim financial statements, compensation reports, and board elections. The title and content are centered around the outcomes of the AGM. This directly corresponds to the 'AGM Information' category.
2024-04-12 English
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
AGM Information Classification · 99% confidence The document explicitly mentions 'Annual General Meeting ("AGM")' multiple times in the headline and body. It details the proposals voted upon, the voting results (majorities), and the outcomes regarding liquidation revocation and board elections. This content directly corresponds to the activities and materials associated with an Annual General Meeting. Although it reports the results, the primary focus is the event itself and the decisions made there, making 'AGM Information' (AGM-R) the most appropriate classification, rather than 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which is usually for the formal declaration *after* the meeting, or 'Proxy Solicitation' (PSI), which precedes the meeting. Since it reports the outcomes of the AGM, AGM-R is the best fit.
2024-04-12 English
Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules
Regulatory Filings Classification · 95% confidence The document is an 'Ad-hoc' announcement released on March 26, 2024, pursuant to Art. 53 LR (Listing Rules). It details that Evolva Holding SA received a temporary exemption from SIX Exchange Regulation AG regarding certain listing conditions, specifically mentioning exemption from the obligation to publish the annual report 2023, maintenance of the corporate calendar, and disclosure of management transactions. Since this document is an announcement *about* regulatory decisions and exemptions, and it is short (4619 chars), it fits the description of a general regulatory announcement that doesn't fit a more specific category like ER, 10-K, or DIV. It is not a presentation (IP), a transcript (CT), or a formal report itself. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory disclosure.
2024-03-26 English
Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g
AGM Information Classification · 98% confidence The document is an 'Ad-hoc' announcement released on March 22, 2024. The headline explicitly states that the company 'publishes liquidation interim financial statements and agenda for 2024 annual general meeting'. It details the financial statements (as of 31 December 2023) and the agenda for the upcoming AGM on April 12, 2024. Since the document contains both the financial results summary for a specific period ('liquidation interim financial statements') and the agenda/materials for the AGM, it covers elements of both an Interim Report (IR) and AGM Information (AGM-R). However, the primary focus is the announcement of the AGM agenda and related proposals, alongside the publication of interim financial statements in the context of liquidation. Given the dual nature, and the explicit mention of the 'agenda for the annual general meeting' and the subsequent detailed discussion of AGM agenda items (including shareholder proposals), classifying it as AGM-R is highly appropriate, as the AGM is a central event being prepared for. The financial statements are presented as 'liquidation interim financial statements' which are part of the overall update leading up to the AGM. Since the document is an announcement that includes the AGM agenda and materials, AGM-R is the most specific fit among the options that cover meeting materials.
2024-03-22 English
Evolva Holding SA in liquidation: Nice & Green requests 3 agenda items be included in AGM agenda
AGM Information Classification · 98% confidence The document is explicitly titled as an 'Ad-hoc' announcement and discusses a shareholder's request to include specific items on the agenda of the upcoming 'Annual General Meeting ("AGM")' scheduled for April 12, 2024. The content focuses entirely on the procedural aspects and proposals related to the AGM, such as revoking liquidation and delisting resolutions. This directly aligns with the definition of 'AGM Information' (AGM-R), which covers presentations and materials shared during the AGM, or materials leading up to it concerning agenda items. Since it is an announcement *about* the AGM agenda items, AGM-R is the most precise fit, rather than a general Regulatory Filing (RNS) or a Proxy Solicitation (PSI), which usually involves the actual voting materials.
2024-03-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.